Adlai Nortye (NASDAQ:ANL) Reaches New 52-Week High - Should You Buy?

Key Points

• Adlai Nortye (NASDAQ:ANL) hit a new 52-week high, trading as high as $14.30 and last at $13.8150 on volume of 195,199 shares (prior close $12.06).
• Analyst coverage is mixed: MarketBeat shows a consensus "Hold" with an average target of $19.50, based on two Buy ratings and one Sell — notable calls include Leerink Partners' $23 outperform and HC Wainwright's $16 buy while Weiss Ratings stayed on sell.
• The stock's technical momentum is strong, with the 50-day and 200-day moving averages at $8.91 and $4.34 respectively, both well below the current price.

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $14.30 and last traded at $13.8150, with a volume of 195199 shares changing hands. The stock had previously closed at $12.06.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ANL. Weiss Ratings reiterated a "sell (e+)" rating on shares of Adlai Nortye in a research note on Wednesday, January 21st. Leerink Partners began coverage on shares of Adlai Nortye in a report on Friday, March 20th. They set an "outperform" rating and a $23.00 target price on the stock. Wall Street Zen upgraded Adlai Nortye to a "hold" rating in a research report on Saturday, March 7th. Finally, HC Wainwright upgraded Adlai Nortye from a "neutral" rating to a "buy" rating and set a $16.00 price target for the company in a research report on Friday, February 13th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $19.50.

Adlai Nortye Stock Performance

The stock's fifty day moving average is $8.91 and its two-hundred day moving average is $4.34.

Adlai Nortye Company Profile

Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.